missing translation for 'onlineSavingsMsg'
Learn More

Thermo Scientific™ Pierce™ Protease Inhibitor Tablets, EDTA-free

Thermo Scientific™ Pierce Protease Inhibitor Tablets are broad-spectrum protease inhibitors that are highly effective at preventing proteolytic degradation for cell lysis and protein extraction experiments

Brand:  Thermo Scientific™ A32965

335.20 EUR valid until 2024-12-31
Use promo code "21745" to get your promotional price.



 View more versions of this product

Product Code. 15677308

  • 362.00€ / Pack of 20
In Stock
to see stock.
Explore more special offers
Add to basket

Alert:

For Research Use Only. Not for use in diagnostic procedures.

This item is not returnable. View return policy

Description

Description

Pierce Protease Inhibitor Tablets protect proteins from proteolytic degradation through inhibition of the serine-proteases, cysteine-proteases, aspartic acid-proteases and aminopeptidases that are typically present in cellular lysate samples. The tablets contain AEBSF, aprotinin, bestatin, E-64, leupeptin and pepstatin A. Stable for storage at 4°C for up to 12 months, each mini or large tablet tablet is sufficient for 10mL or 50mL of solution, respectively, and is suitable for reagent preparation prior to protein extraction from tissue and cultured cells.

Highlights:
  • Improved formulation&mdsashtablets dissolve quickly into a clear solution
  • Economical – more cost-effective than other commercially available formulations for equivalent volumes
  • Convenient&mdsashready-to-use, fully disclosed, broad-spectrum formulations
  • Compatible&mdsashuse directly with Thermo Scientific™ Pierce™ BCA Assays
  • EDTA-free- formulated without EDTA, a metalloproteinase inhibitor (only for EDTA-free formulations)
  • TRUSTED_SUSTAINABILITY
    Specifications

    Specifications

    Protease Inhibitor Cocktail
    Room Temperature
    Pierce™
    Protease Inhibitor
    1 Vial, Store at 2°C to 8°C
    Solid
    50 mL Solution
    20 Tablets
    Product Suggestions

    Product Suggestions

    Videos
    Safety and Handling

    Safety and Handling

    Product Identifier
    • Pierce Protease Inhibitor Tablets, EDTA-Free

    Signal Word
    • Danger

    Hazard Category
    • Serious eye damage/eye irritation Category 1
    • Skin corrosion/irritation Category 1 B

    Hazard Statement
    • H314-Causes severe skin burns and eye damage.
    • H318-Causes serious eye damage.

    Precautionary Statement
    • P264-Wash hands thoroughly after handling.
    • P280-Wear protective gloves/protective clothing/eye protection/face protection.
    • P301+P310-IF SWALLOWED: Immediately call a POISON CENTER/doctor /
    • P303+P361+P353-IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water/ shower.
    • P304+P340-IF INHALED: Remove person to fresh air and keep comfortable for breathing.
    • P305+P351+P338-IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
    • P310-Immediately call a POISON CENTER/doctor/.
    • P330-Rinse mouth.
    • P331-Do NOT induce vomiting.
    • P363-Wash contaminated clothing before reuse.

    Supplemental information
    • MIXTURE LIST-Contains : 4-(2-aminoethyl)-Benzenesulfonyl fluoride hydrochloride

    SDS
    Documents

    Documents

    Certificates
    Special Offers

    Special Offers

    Product Content Correction

    Your input is important to us. Please complete this form to provide feedback related to the content on this product.

    Product Title

    By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

    Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.

    For Research Use Only. Not for use in diagnostic procedures.